Axonics® Reports Third Quarter 2021 Financial Results
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the...
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the...
CHATTANOOGA, Tenn., Nov. 4, 2021 /PRNewswire/ -- Unum Vaccine Verifier™ is now available to help employers navigate the new COVID-19 vaccine...
Felzartamab has the potential to rapidly and substantially reduce anti-PLA2R antibody titers in patients with anti-PLA2R-positive membranous nephropathyPLANEGG/MUNICH, GERMANY /...
Company reports tenth consecutive quarter of triple-digit year-over-year revenue growthStrongest balance sheet since inceptionREDWOOD CITY, CA / ACCESSWIRE / November...
RADIANCE-HTN TRIO and SOLO trial updates demonstrate the durability of blood pressure lowering effects of the Paradise Ultrasound Renal Denervation...
Swope brings years of experience leading customer-centric organizations AUSTIN, Texas--(BUSINESS WIRE)--ESO, the leading data and software company serving emergency medical...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems...
OAKBROOK TERRACE, Ill.--(BUSINESS WIRE)--#EHR--The Delaware-Morrow Mental Health & Recovery Services Board has joined the PartnerSolutions county board collaborative and recently...
Hybrid Event Pairs In-Person Trade Show with Virtual Offerings through SupplySide Network 365 to Provide Opportunities for Innovation Professionals to...
Toronto, Ontario--(Newsfile Corp. - November 4, 2021) - Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) (FSE: 3K70) ("Silo Wellness" or...
Clinically Integrated Network Leverages NextGen® Population Health Solutions to Improve Patient Care While Exceeding Its Savings Objectives for Three Consecutive...
TORONTO, ON / ACCESSWIRE / November 4, 2021 / With COVID-19 affecting daily life in unprecedented ways, the demand for...
- Updates from MANIFEST phase 2 trial in patients with myelofibrosis, including clinical updates on JAK naïve patients treated with...
- REZUROCK™ (belumosudil) 200 mg once daily (QD) tablets are now commercially available for shipment to prescribed patients in the...
TORONTO, ON / ACCESSWIRE / November 4, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic...
Third-Quarter 2021 Results and Highlights:Consolidated revenue of $121 million, comprised of Clinical Services revenue of $102 million and Pharma Services...
FT. MYERS, FL / ACCESSWIRE / November 4, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing...
Instadose Pharma Announces Instadose Canada has Established a Strategic Joint Venture Partner in India Strengthening its Global Distribution PlatformCHESAPEAKE, VA...
Press Release November 4, 2021 Immunicum to Present Data Update on Phase II ADVANCE II at Annual American Society of...
Lund, November 4, 2021 - Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that two abstracts with new preclinical data on...